NO20035763L - Tetrahydrokinolinderivater, farmasøytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet. - Google Patents

Tetrahydrokinolinderivater, farmasøytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet.

Info

Publication number: NO20035763L
Authority: NO; Norway
Prior art keywords: fertility; medicaments; manufacture; well; control
Prior art date: 2001-07-02

Application number

NO20035763A

Other languages

English (en)

Other versions

NO325516B1 (no

Inventor

Nicole Corine Rénee Van Straten

Rudolf Gijsbertus Van Someren

Jurgen Schulz

Original Assignee

Nv Organon

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-02

Filing date

2003-12-22

Publication date

2003-12-29

2003-12-22 Application filed by Nv Organon filed Critical Nv Organon

2003-12-29 Publication of NO20035763L publication Critical patent/NO20035763L/no

2008-06-02 Publication of NO325516B1 publication Critical patent/NO325516B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

NO20035763A 2001-07-02 2003-12-22 Tetrahydrokinolinderivater, farmasoytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet. NO325516B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01202531		2001-07-02
PCT/EP2002/007053 WO2003004028A1 (en)	2001-07-02	2002-06-25	Tetrahydroquinoline derivatives

Publications (2)

Publication Number	Publication Date
NO20035763L true NO20035763L (no)	2003-12-29
NO325516B1 NO325516B1 (no)	2008-06-02

Family

ID=8180574

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035763A NO325516B1 (no)	2001-07-02	2003-12-22	Tetrahydrokinolinderivater, farmasoytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet.

Country Status (31)

Country	Link
US (2)	US8058441B2 (no)
EP (1)	EP1406628B1 (no)
JP (1)	JP4523273B2 (no)
KR (1)	KR100908468B1 (no)
CN (1)	CN1261099C (no)
AR (1)	AR034669A1 (no)
AT (1)	ATE319451T1 (no)
AU (1)	AU2002317848B2 (no)
BR (1)	BR0210645A (no)
CA (1)	CA2452606C (no)
CY (1)	CY1106087T1 (no)
CZ (1)	CZ20042A3 (no)
DE (1)	DE60209734T2 (no)
DK (1)	DK1406628T3 (no)
EC (1)	ECSP034932A (no)
ES (1)	ES2260458T3 (no)
HR (1)	HRP20031080A2 (no)
HU (1)	HUP0400390A2 (no)
IL (1)	IL159288A0 (no)
IS (1)	IS2418B (no)
MX (1)	MXPA03011908A (no)
NO (1)	NO325516B1 (no)
NZ (1)	NZ530198A (no)
PE (1)	PE20030273A1 (no)
PL (1)	PL367638A1 (no)
PT (1)	PT1406628E (no)
RU (1)	RU2347570C2 (no)
SA (1)	SA02230260B1 (no)
SK (1)	SK286759B6 (no)
WO (1)	WO2003004028A1 (no)
ZA (1)	ZA200309921B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL159288A0 (en) *	2001-07-02	2004-06-01	Akzo Nobel Nv	Tetrahydroquinoline derivatives
ES2316777T3 (es) *	2002-02-15	2009-04-16	Glaxo Group Limited	Moduladores de receptores vainilloides.
FR2836618B1 (fr) *	2002-02-28	2004-04-16	Snecma Services	Instrument de projection thermique
SE0200920D0 (sv) *	2002-03-25	2002-03-25	Astrazeneca Ab	Novel compounds
TWI306855B (en) *	2002-12-20	2009-03-01	Organon Nv	Tetrahydroquinoline derivatives
TWI322012B (en) *	2002-12-20	2010-03-21	Organon Nv	Tetrahydroquinoline derivatives
SE0300480D0 (sv) *	2003-02-21	2003-02-21	Astrazeneca Ab	Novel compounds
US20070281931A1 (en) *	2003-05-29	2007-12-06	Nigel Boughton-Smith	Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate
US20070010497A1 (en) *	2003-05-29	2007-01-11	Nigel Boughton-Smith	Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
KR20060037258A (ko) *	2003-05-29	2006-05-03	아스트라제네카 아베	Ｐ2Ｘ7-수용체 길항제 및 종양 괴사 인자 α를 포함하는제약 조성물
GB0312609D0 (en) *	2003-06-02	2003-07-09	Astrazeneca Ab	Novel compounds
KR100554155B1 (ko) *	2003-06-09	2006-02-22	학교법인 포항공과대학교	금속/반도체 나노막대 이종구조를 이용한 전극 구조물 및그 제조 방법
SE0302139D0 (sv) *	2003-07-28	2003-07-28	Astrazeneca Ab	Novel compounds
SE0302192D0 (sv) *	2003-08-08	2003-08-08	Astrazeneca Ab	Novel compounds
SE0302488D0 (sv) *	2003-09-18	2003-09-18	Astrazeneca Ab	New combination
SA05260265A (ar) *	2004-08-30	2005-12-03	استرازينيكا ايه بي	مركبات جديدة
SE0402925D0 (sv) *	2004-11-30	2004-11-30	Astrazeneca Ab	Novel Compounds
US7691848B2 (en)	2005-03-02	2010-04-06	Wyeth	Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists
UA92009C2 (ru) *	2005-05-04	2010-09-27	Н.В. Органон	Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия
UA92007C2 (ru) *	2005-05-04	2010-09-27	Н.В. Органон	Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности
UA92008C2 (en) *	2005-05-04	2010-09-27	Н.В. Органон	4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
JP4869336B2 (ja)	2005-05-04	2012-02-08	ナームローゼ・フエンノートチヤツプ・オルガノン	ジヒドロピリジン誘導体
JP2008540567A (ja)	2005-05-12	2008-11-20	ワイス	卵胞刺激ホルモン受容体（ｆｓｈ−ｒ）アンタゴニストとしてのピロロベンゾジアゼピンおよびヘテロ環状カルボキサミド誘導体
JP2008543765A (ja)	2005-06-09	2008-12-04	ワイス	卵胞刺激ホルモンレセプターアンタゴニストとしてのピロロベンゾジアゼピンピリジンカルボキサミドおよび誘導体
US20070060573A1 (en) *	2005-08-10	2007-03-15	Lars Wortmann	Acyltryptophanols
JP2009504597A (ja) *	2005-08-10	2009-02-05	バイエル・シエーリング・ファーマアクチエンゲゼルシャフト	アシルトリプトファノール
US20080221195A1 (en) *	2006-12-13	2008-09-11	Lars Wortmann	1,2-diarylacetylene derivatives of acyltryptophanols
EP1932831A1 (en) *	2006-12-13	2008-06-18	Bayer Schering Pharma Aktiengesellschaft	1,2-Diarylacetylene Derivatives of Acyltryptophanols
TWI410422B (zh)	2007-01-15	2013-10-01	Mitsubishi Tanabe Pharma Corp	縮合四氫喹啉衍生物及其醫藥用途
TW200848021A (en)	2007-03-06	2008-12-16	Wyeth Corp	Sulfonylated heterocycles useful for modulation of the progesterone receptor
EP2139879B1 (en) *	2007-03-22	2012-07-11	AstraZeneca AB	Quinoline derivatives for the treatment of inflammatory diseases
TW200918058A (en) *	2007-08-31	2009-05-01	Organon Nv	TSH receptor antagonizing tetrahydroquinoline compounds
PE20091036A1 (es)	2007-11-30	2009-08-15	Astrazeneca Ab	Derivado de quinolina como antagonista del receptor p2x7
RU2359684C1 (ru) *	2008-01-23	2009-06-27	Закрытое акционерное общество "СКАЙ ЛТД"	Способ лечения эндометриоза
TW200944523A (en)	2008-02-08	2009-11-01	Organon Nv	(Dihydro)pyrrolo[2,1-a]isoquinolines
US20100061976A1 (en) *	2008-07-24	2010-03-11	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject
US8071587B2 (en)	2009-05-27	2011-12-06	N. V. Organon	(Dihydro)imidazoiso[5,1-A]quinolines
TWI461426B (zh) *	2009-05-27	2014-11-21	Merck Sharp & Dohme	（二氫）咪唑並異〔５，１－ａ〕喹啉類
US8431564B2 (en)	2009-07-29	2013-04-30	Merck Sharp & Dohme B.V.	Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
TW201116531A (en)	2009-07-29	2011-05-16	Organon Nv	Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
TW201116515A (en)	2009-07-31	2011-05-16	Organon Nv	Dihydrobenzoindazoles
HUE025653T2 (hu) *	2010-10-08	2016-04-28	Nivalis Therapeutics Inc	Új, szubsztituált kinolin-vegyületek S-nitrozoglutation-reduktáz inhibitorokként
US8546427B2 (en) *	2010-10-20	2013-10-01	Hoffmann-La Roche Inc.	Tetrahydroquinoline derivatives
WO2016018553A1 (en) *	2014-07-30	2016-02-04	Henkel IP & Holding GmbH	Cure accelerators for anaerobic curable compositions
US12275729B2 (en)	2017-11-01	2025-04-15	Merck Sharp & Dohme Llc	Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
CN119954701A (zh) *	2024-06-18	2025-05-09	青岛润农化工有限公司	一种丁醚脲的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2686182A (en)	1950-12-07	1954-08-10	Basf Ag	O-hydroxy-dihydro-quinoline carboxylic acids
ATE86484T1 (de)	1987-08-08	1993-03-15	Akzo Nv	Kontrazeptives implantat.
EP1041066A1 (en) *	1994-12-22	2000-10-04	Ligand Pharmaceuticals Incorporated	Steroid receptor modulator compounds and methods
US6235755B1 (en) *	1998-08-07	2001-05-22	Applied Research Systems Ars Holding N.A.	FSH mimetics for the treatment of infertility
JP2000143636A (ja) *	1998-09-02	2000-05-26	Sumitomo Pharmaceut Co Ltd	アミノ誘導体
US6200963B1 (en) *	1999-03-31	2001-03-13	American Home Products Corporation	Aryl sulfonic acids as FSH antagonists
IL159288A0 (en)	2001-07-02	2004-06-01	Akzo Nobel Nv	Tetrahydroquinoline derivatives
TWI306855B (en)	2002-12-20	2009-03-01	Organon Nv	Tetrahydroquinoline derivatives
TWI322012B (en)	2002-12-20	2010-03-21	Organon Nv	Tetrahydroquinoline derivatives

2002
- 2002-06-25 IL IL15928802A patent/IL159288A0/xx not_active IP Right Cessation
- 2002-06-25 SK SK1634-2003A patent/SK286759B6/sk not_active IP Right Cessation
- 2002-06-25 AT AT02747437T patent/ATE319451T1/de not_active IP Right Cessation
- 2002-06-25 CA CA2452606A patent/CA2452606C/en not_active Expired - Fee Related
- 2002-06-25 PT PT02747437T patent/PT1406628E/pt unknown
- 2002-06-25 DE DE60209734T patent/DE60209734T2/de not_active Expired - Lifetime
- 2002-06-25 RU RU2004102693/15A patent/RU2347570C2/ru not_active IP Right Cessation
- 2002-06-25 WO PCT/EP2002/007053 patent/WO2003004028A1/en not_active Ceased
- 2002-06-25 DK DK02747437T patent/DK1406628T3/da active
- 2002-06-25 PL PL02367638A patent/PL367638A1/xx unknown
- 2002-06-25 CN CNB02813334XA patent/CN1261099C/zh not_active Expired - Fee Related
- 2002-06-25 ES ES02747437T patent/ES2260458T3/es not_active Expired - Lifetime
- 2002-06-25 BR BR0210645-0A patent/BR0210645A/pt not_active IP Right Cessation
- 2002-06-25 JP JP2003510039A patent/JP4523273B2/ja not_active Expired - Fee Related
- 2002-06-25 NZ NZ530198A patent/NZ530198A/en not_active IP Right Cessation
- 2002-06-25 CZ CZ20042A patent/CZ20042A3/cs unknown
- 2002-06-25 EP EP02747437A patent/EP1406628B1/en not_active Expired - Lifetime
- 2002-06-25 AU AU2002317848A patent/AU2002317848B2/en not_active Ceased
- 2002-06-25 MX MXPA03011908A patent/MXPA03011908A/es active IP Right Grant
- 2002-06-25 HR HR20031080A patent/HRP20031080A2/hr not_active Application Discontinuation
- 2002-06-25 US US10/482,707 patent/US8058441B2/en not_active Expired - Fee Related
- 2002-06-25 HU HU0400390A patent/HUP0400390A2/hu unknown
- 2002-06-25 KR KR1020037017088A patent/KR100908468B1/ko not_active Expired - Fee Related
- 2002-06-27 PE PE2002000581A patent/PE20030273A1/es not_active Application Discontinuation
- 2002-07-01 AR ARP020102468A patent/AR034669A1/es unknown
- 2002-08-26 SA SA02230260A patent/SA02230260B1/ar unknown
2003
- 2003-12-11 IS IS7071A patent/IS2418B/is unknown
- 2003-12-22 ZA ZA200309921A patent/ZA200309921B/en unknown
- 2003-12-22 NO NO20035763A patent/NO325516B1/no not_active IP Right Cessation
- 2003-12-30 EC EC2003004932A patent/ECSP034932A/es unknown
2006
- 2006-05-16 CY CY20061100628T patent/CY1106087T1/el unknown
2011
- 2011-10-07 US US13/268,214 patent/US8258293B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HK1061810A1 (en)	2004-10-08
AU2002317848B2 (en)	2006-08-31
CY1106087T1 (el)	2011-06-08
US8258293B2 (en)	2012-09-04
DK1406628T3 (da)	2006-07-03
CN1529601A (zh)	2004-09-15
SK16342003A3 (sk)	2004-07-07
WO2003004028A1 (en)	2003-01-16
EP1406628A1 (en)	2004-04-14
NO325516B1 (no)	2008-06-02
IS7071A (is)	2003-12-11
CZ20042A3 (en)	2004-04-14
IL159288A0 (en)	2004-06-01
EP1406628B1 (en)	2006-03-08
CA2452606C (en)	2011-09-13
RU2004102693A (ru)	2005-06-27
US20040236109A1 (en)	2004-11-25
KR20040030714A (ko)	2004-04-09
CN1261099C (zh)	2006-06-28
SK286759B6 (sk)	2009-05-07
CA2452606A1 (en)	2003-01-16
HRP20031080A2 (en)	2004-04-30
BR0210645A (pt)	2004-10-05
NZ530198A (en)	2005-11-25
AR034669A1 (es)	2004-03-03
US20120202996A1 (en)	2012-08-09
JP4523273B2 (ja)	2010-08-11
SA02230260B1 (ar)	2007-03-25
JP2004535456A (ja)	2004-11-25
PL367638A1 (en)	2005-03-07
MXPA03011908A (es)	2004-06-03
US8058441B2 (en)	2011-11-15
KR100908468B1 (ko)	2009-07-21
ECSP034932A (es)	2004-02-26
ES2260458T3 (es)	2006-11-01
IS2418B (is)	2008-10-15
HUP0400390A2 (hu)	2004-09-28
ZA200309921B (en)	2005-03-22
PT1406628E (pt)	2006-06-30
PE20030273A1 (es)	2003-03-21
RU2347570C2 (ru)	2009-02-27
DE60209734D1 (de)	2006-05-04
DE60209734T2 (de)	2006-08-31
ATE319451T1 (de)	2006-03-15

Publication	Publication Date	Title
NO20035763L (no)	2003-12-29	Tetrahydrokinolinderivater, farmasøytiske preparater omfattende slike samt anvendelse av slike for fremstilling av medikament for kontroll av fruktbarhet.
NO20041277L (no)	2004-03-26	Farmasoytiske preparater for behandling av astma.
DK1263720T3 (da)	2009-09-28	Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
EE201300011A (et)	2013-06-17	Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
NO324227B1 (no)	2007-09-10	Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
NO20024176L (no)	2002-10-29	Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
MXPA03000873A (es)	2003-06-06	Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
HUP0401648A3 (en)	2007-05-29	6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same
NO20032187L (no)	2003-06-26	Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
IL168266A (en)	2010-11-30	Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments
DK1345910T3 (da)	2009-07-20	Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20042739L (no)	2004-07-23	Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
MXPA03001483A (es)	2003-06-06	Heterociclos biciclicos medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion.
WO2003080582A3 (de)	2004-12-09	Fredericamycin-derivate
EP1391200A4 (en)	2004-06-16	DRUG
NO992102L (no)	2000-10-31	Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
MXPA03006538A (es)	2003-09-22	Nuevos derivados de urea, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
MXPA03001510A (es)	2003-06-09	Heterociclos biciclicos, medicamentos que contiene estos compuestos, su empleo y procedimientos para su preparacion.
ZA200102589B (en)	2002-02-27	Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof.
DE60006958D1 (de)	2004-01-15	Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
NO326689B1 (no)	2009-01-26	Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
IS5730A (is)	2000-11-24	Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni
DK1118610T3 (da)	2002-12-16	Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
NO20035163D0 (no)	2003-11-20	Nye piperidinkarboksamid-derivater, fremgangsmåte for deres fremstilling ogfarmasöytiske preparater inneholdende de samme
NO20024590L (no)	2002-09-25	Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling

Legal Events

Date	Code	Title	Description
2011-01-31	MM1K	Lapsed by not paying the annual fees